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Abstract
Objective: This study was designed to (1) investigate the expression profiles of resistin in db/db mice and its dynamic
association with metabolic parameters; and (2) evaluate the effects of Rosiglitazone on production of resistin.
Methods: Db/db mice and their lean litter mates were used for this study. Epididymal fat tissue was excised from mice of
different age (from 5 to 12 weeks) for ex vivo incubation. Resistin,along with adiponectin,in serum and conditioned culture
medium of epididymal fat pads were measured with immunoassays. The gene expression of resistin was determined by
real-time PCR. Rosiglitazone or the vehicle (PBS) was administered into db/db mice by daily intra-gastric gavage.
Differentiated 3T3-L1 adipocytes were used for in vitro evaluation.
Results: The secretion of resistin from the fat pads in db/db mice was significantly lower than that in lean mice (P,0.01).
The mRNA expression of the resistin gene in fat tissue of db/db mice at the age of 5 weeks was decreased by 60.5%
compared to lean controls (p,0.05). Serum levels of resistin were comparable between the obese and lean groups, perhaps
due to the increased total fat mass in db/db mice. Correlation analysis showed that serum resistin levels were positively
correlated to resistin secretion from fat pads(r = 0.844,P = 0.000), while negatively associated with the body weight
(r =20.515, P = 0.000) and fasting glucose level (r =20.357, P = 0.002). Notably, treatment with rosiglitazone increased the
serum resistin levels by 66.4%(P,0.05)in db/db mice. In 3T3-L1 adipocytes, Rosiglitazone (10 uM) markedly enhanced the
secretion of resistin by 120% (P,0.01) and its gene expression by 78.1% (P,0.05).
Conclusion: Both resistin gene expression and its secretion from the epididymal adipose tissue were decreased in db/db
obese mice, while the insulin-sensitizing drug rosiglitazone increased resistin production. Our results do not support the
role of resistin as an etiological link between obesity and diabetes.
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Introduction
Adipose tissue(AT) is known to produce a vast array of
adipokines, which are implicated in the pathogenesis of the
metabolic syndrome. Such factors include TNF-a (tumour necrosis
factor-a), leptin, adiponectin, IL (interleukin) 26 and resistin [1–
3].
Resistin, an adipocyte-derived signaling polypeptide, was
originally identified in 2001 [4,5]. Initial studies [5] showed that
circulating resistin levels were increased in diet-induced and
genetic obesity mice and decreased by the anti-diabetic drug
rosiglitazone. Administration of anti-resistin antibody improved
blood sugar and insulin action in mice with diet-induced obesity.
Moreover, treatment of normal mice with recombinant resistin
impairs glucose tolerance and insulin action. These observations
characterized resistin as a potential etiological link between obesity
and diabetes.
However, to date there has been considerable inconsistent
reports from the animal and clinical studies for or against the role
for resistin as an important pathogenic factor in obesity, insulin
resistance and type 2 diabetes [6,7]. There are many results that
support the role of resistin as an important pathogenic factor in
obesity and related disorders: higher serum level of resistin in the
various murine genetic or diet-induced model of obesity [5];
positive correlation between the resistin serum level, gene
expression level and BMI, degree of insulin resistance [8]; down-
regulation by Rosiglitazone treatment [9,10].
There were also many controversial results against the role of
resistin in the relation between obesity and its related diseases.
Way JM et al [11] firstly reported that resistin gene expression was
significantly decreased in the white adipose tissue (WAT) of several
different models of obesity including the ob/ob, db/db, tub/tub,
and KKA(y) mice compared with their lean counterparts.
Furthermore, in response to several different classes of antidiabetic
peroxisome proliferator-activated receptor (PPAR)-c agonists,
resistin gene expression in WAT was increased in both ob/ob
mice and Zucker diabetic fatty rats. Furthermore, an improvement
of insulin sensitivity after PPAR-a agonist treatment is accompa-
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nied by paradoxical increase of circulating resistin Levels [12]. In
human, Janowska J [13] and Pfutzner A [14] reported that serum
resistin concentrations did not correlate with BMI, HOMA,
fasting plasma glucose level, or fasting plasma insulin level, and
Wasim H et al found that there were no significant difference
among NGT, IGT and new diagnosed type 2 DM [15], plasma
levels of resistin in subjects with CAD or diabetes are similar to the
controls [16].
Therefore, the role of resistin in obesity-associated insulin
resistance remains unclear.
In this study, we investigated the expression profiles of resistin of
AT in db/db obese/diabetic mice at different age (from 5 to 12
weeks) and its association with metabolic parameters, and
evaluated the effects of Rosiglitazone on production of resistin.
And the time courses of adiponectin in serum and production from
the fat pads were investigated at the same time.
Materials and Methods
Animals
Male C57BKS db/db diabetic mice and lean litter mates at the
age of 5,6,7,8,10 and 12 weeks were used in this study(the numbers
of db/db mice at each time point were 9,5,5,6,5 and 6; while the
numbers of lean control were 8,6,8,7,5,and 5). The mice were
housed in a room under controlled temperature (2361uC) and a
light-dark cycle (12:12), with free access to water and standard
mouse chow. Intraperitoneal glucose tolerance test (ipGTT) was
performed to assess the glucose metabolic situation 3 days before
sacrifice. Blood glucose was checked from the tail vein with
glucosemeter (ACCU-CHEKH, Roche) before and 10, 20, 30,45,
60,75,90 min after the glucose injection intraperitoneally at a dose
of 1 mg/g. At the sacrificing day, after a 6h fast, body weight was
recorded; blood sample was collected through cardiac puncture
and serum was separated and stored at 220uC for further assay.
Epididymal, perirenal and abodomal AT were collected and
weighted, epididymal AT was freshly prepared for explants
incubation and frozen then stored for RNA analysis.
Rosiglitazone (20 mg/kg/day) or the vehicle (PBS) was admin-
istered into other 10 db/db mice at the age of 10 weeks by daily
intra-gastric gavage for 4 weeks. Random blood glucose (RBG)
was checked from the tail vein with glucosemeter (ACCU-CHEKH,
Roche). Blood sample was collected through cardiac puncture and
serum was separated and stored at 220uC for resistin assay.
All experiments were approved by the Animal Ethics Commit-
tee of the University of Hong Kong and conducted under the
institutional guidelines for the humane treatment of laboratory
animals.
Adipose Tissue Explants Incubation [17]
In db/db mice, epididymal AT(200,300 mg) was collected in
duplicate while adipose tissue from 3,5 lean mice were pooled
together for incubation. The handling of tissue was done under
aseptic conditions. After rinsed with prewarmed PBS and cut with
scissors into small pieces (10–20 mg), explants of AT were
Figure 1. The time course of body weight (BW) and total adipose tissue (tAT) percentage of BW. At the age of 5 week, BW was
comparable between db/db mice and lean control. Db/db mice older than 6W had higher BW than lean control (Figure 1A). At each time point,
tAT(all AT from epididymal, perirenal and abodomal) percentage of body weight(BW) from db/db mice were significantly higher than lean
control(Figure 1B), indicating that fat tissue mass increased markedly in db/db mice from 5 weeks old.*P,0.01,compared with lean control at the
same age.
doi:10.1371/journal.pone.0065543.g001
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incubated in Dulbecco’s modified Eagle’s medium/Ham’s F12
(1:1, Sigma No. 2906) containing 25 mM Hepes, 2.4 mM sodium
bicarbonate, 10 mg/ml bovine serum albumin, 10,000 U/ml
Penicillin, 10 mg/ml Streptomycin, 25 ug/ml amphotericin B and
55 mM ascorbic acid(The pH of the buffer was adjusted to 7.2 and
then filtered through a 0.2-mm filter) for 30 min in water bath
orbitally shaking at 80rpm(Grant OSL200) at 37uC with air as the
gas phase, then centrifuged for 30 s at 400 g to remove
erythrocytes and pieces of tissues. The explants were separated
from the medium plus the sedimented cells and resuspended in
fresh buffer. The explants (200 mg/ml) were then incubated for
24h in suspension culture under aseptic conditions. After 24h
incubation, medium was collected and stored at220uC for further
assay.
Cell Culture
3T3-L1 cells were cultured in Dubecco’s modified Eagle’s
medium (Gibco) supplemented with 10% feta bovine serum.
Adipocyte differentiation was induced as we previously described
[18].The adipocyte conditioned medium was collected after 48h
incubation with or without Rosiglitazone (10 uM). Meanwhile, the
adipocytes were collected in Trizol for further RNA evaluation.
Immunoassay
Resistin level in serum, explants incubation medium(EIM) and
conditioned medium from 3T3-L1 adipocytes was measured using
an in house ELISA assay. Capture antibody for resistin (R&D
system, MAB1069), biotinylated detection antibody (R&D system,
BAF1069) and standard (R&D system, 1069-RN) were purchased
from R&D systems, Inc. The assay was performed according to
the manufacturers’ protocols. Adiponectin level in serum and EIM
were measured using an in house ELISA assay [19].
Evaluation of the Resistin Gene Expression Levels by
Quantitative Real-time RT-PCR
Total RNA was extracted from adipose tissue and adipocytes
using Trizol reagent (Invitrogen). One microgram of total RNA
was transcribed into cDNA using ImProm-II Reverse. Each cDNA
sample was analyzed for gene expression by quantitative real-time
PCR using the fluorescent TaqMan 59-uclease assay on an
Applied Biosystems Prism 7000 sequence detection system. The
TaqMan real-time PCR was performed using 206TaqMan
Master Mix and 206assay-on-demand TaqMan primers and
probes (Applied Biosystems). Analysis was performed with ABI
Prism 7000 SDS Software. The sequences of primers are: Forward
59-GGCTCTGTGCTCCTCCATCT-39, Reverse 5 ’-
AGAGTCGTTGACGTTATCTGCATAG-39, Probe FAM-59-
CCCATACACCTGGAGCCAGACTTGGT-39-TAMRA.
The homeostasis model assessment (HOMA) of insulin resis-
tance (HOMA-IR) was calculated with the following formula:
fasting plasma glucose (FPG, mmol/L) 6fasting insulin (FINS,
mIU/L)/22.5, HOMA of beta-cell function (HOMA-B) with
206FINS/(FPG-3.5).
Figure 2. Time course of serum insulin level and glucose metabolism situation of mice. Figure 2A showed that db/db obese mice had
higher level of insulin at each time point than lean control. * p,0.05 **p,0.01 vs lean control at same age. Compared with the lean group, db/db
obese mice had normal response to intraperitoneal glucose tolerance test(ipGTT) at the age of 5w, had impaired ipGTT at the age of 6w and
increased fasting glucose level at the age of 10w (Fig. 2B).
doi:10.1371/journal.pone.0065543.g002
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Statistics
All analyses were performed with the Statistical Package for
Social Sciences version 14.0 (SPSS, Chicago. IL). Data are
expressed as means6 standard deviation (SD). The inter-group
comparisons were made by Student’s t test or one-way ANOVA.
In all statistical comparisons, a P value of less than 0.05 was
considered statistically significant. The experiments in cell culture
were reproduced in three independent experiments.
Results
1. Time Course of Body Weight, Adipose Tissue, Glucose,
and Circulating Resistin Level in db/db Mice
At the age of 5 weeks, body weight (BW) was comparable
between db/db mice and lean control while adipose tissue weight
of epididymal, perirenal and abdominal subcutaneous depots and
its percentage of BW from db/db mice were significantly higher
than lean control, indicating that fat tissue mass increased
markedly in db/db mice. Along with the growing, db/db mice
had higher BW and higher percentage of adipose tissue
(Fig. 1A,1B).
Compared with the lean group, db/db mice had normal
response to ipGTT but increased insulin level at the age of 5
weeks, had impaired ipGTT (IGT) at the age of 6 weeks and
increased fasting glucose level at the age of 10 weeks (Fig. 2A, 2B).
At the age of 5 weeks and 6 weeks, db/db mice had higher level
of resistin than lean control. Serum levels of resistin were
comparable between the db/db obese and lean group at the older
age (Fig. 3A). And correlation analysis of all mice showed that
serum resistin levels were negatively correlated to the body weight
(BW)(r =20.515, P= 0.000, Fig. 3B) and fasting blood glucose
level (r =20.357, P= 0.002, Fig. 3C). The serum resistin level is
not correlated with HOMA-IR (r =20.194, P = 0.103) or
HOMA-B(r =20.187, P= 0.116) or fasting insulin le-
vel(r =20.035, P= 0.773).
2. Time Course of Resistin Production ex vivo
At each time point, resistin production from the explants of
epididymal WAT was decreased in db/db obese mice compared
with lean control mice (Fig. 4A). And in db/db mice, resistin in the
explants incubation medium was positively correlated with resistin
level in the serum (r = 0.844, P= 0.000, Fig. 4B).
Figure 3. Time course of circulating resistin level at different age and its relation to body weight (BW) and fasting blood glucose
(fBG). Fig. 3A showed that db/db mice had higher serom level of resistin than lean control at the age of 5 weeks and 6 weeks. * p,0.05 **p,0.01 vs
lean control. While serum levels of resistin were comparable between the obese and lean group at the older age. Fig. 3B showed the negative
correlation between the circulating resistin level and body weight(BW)(r =20.515, P = 0.000); Fig. 3C showed the negative correlation between the
circulating resistin level and fasting blood glucose (fBG) (r =20.357, P = 0.002).
doi:10.1371/journal.pone.0065543.g003
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3. mRNA Expression of the Resistin Gene in the
Epididymal AT
Real time PCR showed that mRNA expression of the resistin
gene in the epididymal AT of db/db mice at the age of 5 weeks
was decreased by 60.5% compared to their lean controls (P,0.05,
Fig. 5).
4. The Effect of Rosiglitazone on Resistin Expression and
Secretion in vitro and in vivo
Notably, treatment of db/db mice with Rosiglitazone for 4
weeks increased the serum resistin levels by 66.4% (P,0.05, Fig. 6)
while significantly improved RBG level (7.260.95 mmol/L vs
21.862.2 mmol/L in db/db control, p,0.01). And in adipocytes
differentiated from 3T3-L1, the treatment of Rosiglitazone
(10 uM) markedly enhanced the secretion of resistin by 120%
(P,0.01, Fig. 7A) and its gene expression by 78.1% (P,0.01,
Fig. 7B).
5. Adiponectin Level in Serum and Production from the
Epididymal Adipose Tissue
At each point, adiponectin level in the serum was comparable
between db/db mice and lean mice(P.0.05), while adiponectin
level in the explants incubation medium (EIM) of the db/db mice
was much lower than that of lean mice at the age of 5, 6 and 7
weeks (Fig. 8A,8B).
Discussion
Obesity is a well-known risk factor for the development of
insulin resistance and the metabolic syndrome. Adipose tissue is
currently known to secrete a large number of factors with
diverse functions. These factors include free fatty acids (FFA)
and proteins, termed adipokines, which act in an autocrine,
paracrine, or endocrine fashion to control various metabolic
functions. Some of these adipocytokines have been implicated in
the development of insulin resistance. Accumulating experi-
mental evidence indicates that adiponectin possesses anti-
diabetic and anti-inflammatory properties [20,21]. However,
the precise physiological and pathological roles of adipokines,
especially resistin, have still not been established unequivocally
[1–3].
In the present study, we sought to investigate the expression
profiles of resistin in db/db mice, a widely used classical model
of obesity and diabetes, at different ages (from 5 to 12 weeks)
and its association with metabolic parameters. To the best of
our knowledge, this study is the first report showing the time
course of the serum resistin level and resistin production from
the adipose tissue in db/db mice. We found that at the age of 5
weeks and 6 weeks, db/db mice had higher level of resistin
than lean control, serum levels of resistin were comparable
between the obese and lean group at the older age. But at the
age of 5 weeks, the resistin gene expression in the epididymal
adipose tissue of db/db mice was decreased by 60.5%
Figure 4. Time course of resistin level in the explants incubation medium (EIM) and its relation to serum resistin level. At each time
point, resistin production was decreased in db/db mice(vs lean control at the same age *P,0.05, **P,0.01, Fig. 4A); Fig. 4B showed the positive
correlation between the resistin level in the explants incubation medium and the resistin level in the serum (r = 0.844 P = 0.000).
doi:10.1371/journal.pone.0065543.g004
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compared to their lean controls, and the resistin production
from the epididymal adipose tissue was decreased by 43.7%
compared to their lean controls. There is a further decrease of
resistin production with the older age. At the age of 12 weeks,
resistin production in db/db mice was only 23.4% of that from
lean control mice. So, the profile of the resistin serum level can
be explained by the increased total fat mass along with the
decreased expression and production of resistin from the
adipose tissue in db/db mice.
The results of the correlation analysis showed that serum resistin
levels were negatively correlated to the body weight and fasting
glucose level but not correlated with HOMA-IR or HOMA-B or
fasting insulin level.
In db/db mice, resistin in the explants incubation medium of
the epididymal adipose tissue was positively correlated with resistin
level in the serum. This indicated that the epididymal adipose
tissue maybe the major source of resistin in db/db mice.
Steppan CM [5] reported that increased circulating resistin
levels in diet-induced and genetic obesity could be decreased by
rosiglitazon. Way JM et al [11] reported that PPAR-c agonist such
as rosiglitazone increased the resistin expression from WAT in ob/
ob mice, but they did not report the change of serum resistin level.
In our study, we found that treatment with Rosiglitazone for 4
weeks increased the serum level of resistin in db/db mice. These
in vitro results were consistent with the notion that rosiglitazone
markedly increased the resistin gene expression and secretion in
adipocytes differenciated from 3T3L1.
Therefore, our results suggest that resistin is not an etiological
link between obesity and diabetes.
Besides the time courses of serum adiponectin and production
from adipose tissue, we performed further experiments to
investigate the role of adiponectin in the inflammation of adipose
tissue when mice become obese. The results(unpublished data)
showed that the reduction in adiponectin production emerges
along with insulin resistance and fat mass increase, precedes the
macrophage infiltration in the adipose tissue;and epididymal
adipose tissue explants incubation medium (EIM )of the db/db
mice had stronger chemotaxic effect than their lean controls.
Globular adiponectin (20 ug/ml) added to the EIM can weaken
their chemotaxic effects on monocytes(THP-1).The decreased
adiponectin expression and production may, at least in part,
contribute to the chronic inflammation in the white adipose tissue
in db/db mice.
In recent years, the numbers of adipokines discovered has
expanded rapidly [20]. Adipokines include adiponectin, resistin,
visfatin, apelin, retinol binding protein-4, plasminogen activator
inhibitor-1, angiotensinogen, vaspin, omentin, and so on. The
profiles of adipokines change in response to the change of adipose
tissue mass, and are found to play a role in the link between obesity
and insulin resistance. But it is still not well known which one
maybe the trigger for insulin resistance in obesity.
Figure 5. The resistin gene expression in the epididymal
adipose tissue at the age of 5 weeks. Total RNA purified from
these samples was subjected to quantitative PCR analysis to determine
the mRNA levels of resistin. Data were normalized against 18s ribosomal
RNA. For comparison, the gene expression levels in the lean control mice
were arbitrarily set at 1. **p,0.01 vs lean control.
doi:10.1371/journal.pone.0065543.g005
Figure 6. Treatment with Rosiglitazone increased the serum
resistin level of db/db mice. Db/db mice were treated with PBS
(control) or Rosiglitazone (20 mg/kg/day) by daily intra-gastric gavage
for 4 weeks. The db/db mice treated with Rosiglitazone (Rosi) had
higher level of serum resistin vs control(*P,0.05).
doi:10.1371/journal.pone.0065543.g006
Figure 7. Effects of Rosiglitazone on the protein production
and gene expression of resistin in adipocytes differentiated
from 3T3-L1. Fully differentiated 3T3-L1 adipocytes were cultured
with or without Rosiglitazone (10 uM) for 48 h. The resistin in the
conditioned medium was measured (Fig. 7A). Total RNA purified from
these samples was subjected to quantitative PCR analysis to determine
the mRNA levels of resistin. Data were normalized against 18 s
ribosomal RNA. For comparison, the levels of the resistin without
Rosiglitazone were arbitrarily set at 1(Fig. 7B). The results were repeated
for three times and expressed as mean 6S. vs control,
*p,0.05**p,0.01.
doi:10.1371/journal.pone.0065543.g007
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